Status:
UNKNOWN
Angiotensin Metabolite Profile After Subarachnoid Hemorrhage
Lead Sponsor:
Dr. Roman Ullrich
Collaborating Sponsors:
Austrian Science Fund (FWF)
Conditions:
Subarachnoid Hemorrhage, Aneurysmal
Eligibility:
All Genders
18-85 years
Brief Summary
The outcome of subarchnoid hemorrhage depends on the severity of the bleeding and the development of secondary neurologic deficits caused by cerebral vasospasm. The primary endpoint is a comparison of...
Detailed Description
Wider research context. The clinical course and neurological outcome of patients with subarachnoid hemorrhage following rupture of an intracranial aneurysm depend on surgical repair of the ruptured an...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of subarachnoid hemorrhage because of aneurysmal rupture admitted to the ICU
- Invasive monitoring of arterial blood pressure
Exclusion
- Patients who decline study participation
- Brain stem death
- Chronic renal impairment with creatinine \> 2mg/dL or hemodialysis
- Chronic liver failure of Child Pugh class C or higher
- Chronic heart failure
- Hormone producing neuroendocrine tumor
- Sarcoidosis
- Pregnancy
- Planned transfer to another hospital shortly after aneurysm repair
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05222542
Start Date
March 1 2022
End Date
February 1 2025
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, A-1090